Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Am J Psychiatry ; 158(4): 605-10, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11282696

RESUMO

OBJECTIVE: Elevated D8/17 expression on B lymphocytes is a known susceptibility marker of rheumatic fever. Previous studies have reported higher than usual D8/17 expression on B lymphocytes of patients with tic disorders. The purpose of this study was to assess D8/17 expression on B lymphocytes of tic disorder patients by using an objective method in which no operator variability was involved. METHOD: D8/17 expression on B lymphocytes was assessed with flow cytometry by using an immunoglobulin M (IgM) monoclonal D8/17-specific antibody in an unselected group of Dutch patients with tic disorders (N=33) and healthy volunteers (N=20). Binding of this monoclonal antibody was compared with binding of an irrelevant IgM monoclonal antibody, and the shift in mean fluorescence intensity of the D8/17-specific antibody compared to that of the irrelevant IgM monoclonal antibody was used as a measure of D8/17 overexpression. For the patients, Yale Global Tic Severity Scale scores were used to assess disease severity. RESULTS: D8/17 overexpression in the patient group (mean=16.8 arbitrary units, SD=30.5) was significantly higher than in the comparison group (mean=3.2, SD=3.0). A significant minority of the patients (N=13, 39.4%), however, had levels of D8/17 overexpression within the range of that of the healthy comparison subjects. Flow cytometric analysis did not indicate a separate subpopulation of D8/17-positive B cells. CONCLUSIONS: These data confirm the utility of D8/17 B cell overexpression as a peripheral blood marker in patients with tic disorders and are compatible with a streptococcus-related pathogenesis for at least a subgroup of patients with tic disorders.


Assuntos
Anticorpos Monoclonais/imunologia , Antígenos/imunologia , Linfócitos B/imunologia , Transtornos de Tique/imunologia , Adolescente , Adulto , Anticorpos Monoclonais/metabolismo , Antígenos/análise , Autoimunidade/imunologia , Linfócitos B/metabolismo , Biomarcadores , Criança , Feminino , Citometria de Fluxo , Humanos , Imunoglobulina M/imunologia , Masculino , Escalas de Graduação Psiquiátrica/estatística & dados numéricos , Febre Reumática/imunologia , Índice de Gravidade de Doença , Infecções Estreptocócicas/imunologia , Streptococcus/imunologia , Transtornos de Tique/diagnóstico
2.
Br J Dermatol ; 112(4): 387-92, 1985 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2986669

RESUMO

We report an investigation of peripheral blood polymorphonuclear leukocytes (PMN) from untreated patients with mild, quiescent psoriasis. Four aspects of the 'metabolic burst' were measured to illustrate phagocytosis-related events. These were: myeloperoxidase activity, hydrogen peroxide release, superoxide production and luminol-amplified chemiluminescence. Our study does not support the concept of an intrinsic abnormality of the PMN in psoriasis, but provides additional evidence for disease activity-dependent changes in phagocytic behaviour. Possible interactions with certain humoral factors, the so-called opsonins, are discussed.


Assuntos
Neutrófilos/metabolismo , Psoríase/sangue , Adulto , Humanos , Peróxido de Hidrogênio/sangue , Medições Luminescentes , Pessoa de Meia-Idade , Neutrófilos/enzimologia , Peroxidase/sangue , Psoríase/enzimologia , Superóxidos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA